SUBSTIPHARM
Marwa Abbassi is a Senior European Regulatory Affairs Project Manager at Substipharm, with previous experience in various roles within the pharmaceutical industry. With a background in biotechnology and industrial biology, Marwa has worked on projects related to quality control, research on toxins produced by fungi, and the optimization of magnetic nanovectors for cancer treatment. Marwa holds a Master's degree in regulatory affairs, quality, and production of health products, showcasing their expertise in the field.
SUBSTIPHARM
Substipharm is a privately held pharmaceutical Group. We develop, supply and commercialize pharmaceuticals in more than 60 countries worldwide. Our portfolio of products that we currently license out or distribute directly or through partners comprises more than 60 different molecules. Our development pipeline includes as well more than 40 ongoing projects. We have a successful portfolio of pharmaceutical products and vaccines including: Mature brands Generics Over the counter (OTC) pharmaceuticals Difficult to develop medicines Value added presentations Biological products including vaccines: